- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
CH625 is a potent and selective competitive inhibitor of CYP4X1 that decreases tumor burden, increases survival in glioma intracranial and subcutaneous model in rats. CH625 normalizes tumor vasculature in the C6 and GL261 gliomas through tumor-associated macrophages (TAMs) reprograming and inhibition of VEGF and TGF-β production.
potent and selective competitive inhibitor of CYP4X1 that decreases tumor burden, increases survival in gliomas
| Quality Segment | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | 2-8°C |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
询价
-
询价
-
询价
-
¥ 238.17
-
询价
-
¥ 4968.78
-
¥ 4897.21
-
¥ 1568.60
-
¥ 1196.00
-
¥ 3852.13
-
¥ 1196.14
-
¥ 2173.94
-
询价
-
¥ 165230.53
-
询价
-
询价
-
¥ 51962.23
-
¥ 21144.84
-
¥ 3704.60
微信小程序
7X24小时在线咨询